BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38953211)

  • 1. Multisite Validation of a Functional Assay to Adjudicate
    Ma JG; O'Neill MJ; Richardson E; Thomson KL; Ingles J; Muhammad A; Solus JF; Davogustto G; Anderson KC; Shoemaker MB; Stergachis AB; Floyd BJ; Dunn K; Parikh VN; ChubbW H; Perrin MJ; Roden DM; Vandenberg JI; Ng CA; Glazer AM
    Circ Genom Precis Med; 2024 Jul; ():e004569. PubMed ID: 38953211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-site validation of a functional assay to adjudicate
    Ma JG; O'Neill MJ; Richardson E; Thomson KL; Ingles J; Muhammad A; Solus JF; Davogustto G; Anderson KC; Benjamin Shoemaker M; Stergachis AB; Floyd BJ; Dunn K; Parikh VN; Chubb H; Perrin MJ; Roden DM; Vandenberg JI; Ng CA; Glazer AM
    medRxiv; 2023 Dec; ():. PubMed ID: 38196587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Reclassification of SCN5A Variants.
    Glazer AM; Wada Y; Li B; Muhammad A; Kalash OR; O'Neill MJ; Shields T; Hall L; Short L; Blair MA; Kroncke BM; Capra JA; Roden DM
    Am J Hum Genet; 2020 Jul; 107(1):111-123. PubMed ID: 32533946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ParSE-seq: A Calibrated Multiplexed Assay to Facilitate the Clinical Classification of Putative Splice-altering Variants.
    O'Neill MJ; Yang T; Laudeman J; Calandranis M; Solus J; Roden DM; Glazer AM
    medRxiv; 2023 Sep; ():. PubMed ID: 37732247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic re-evaluation of SCN5A variants associated with Brugada syndrome.
    Denham NC; Pearman CM; Ding WY; Waktare J; Gupta D; Snowdon R; Hall M; Cooper R; Modi S; Todd D; Mahida S
    J Cardiovasc Electrophysiol; 2019 Jan; 30(1):118-127. PubMed ID: 30203441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Testing in Brugada Syndrome: A 30-Year Experience.
    Pannone L; Bisignani A; Osei R; Gauthey A; Sorgente A; Monaco C; Della Rocca DG; Del Monte A; Strazdas A; Mojica J; Al Housari M; Miraglia V; Mouram S; Vetta G; Paparella G; Ramak R; Overeinder I; Bala G; Almorad A; Ströker E; Pappaert G; Sieira J; de Ravel T; La Meir M; Sarkozy A; Brugada P; Chierchia GB; Van Dooren S; de Asmundis C
    Circ Arrhythm Electrophysiol; 2024 Apr; 17(4):e012374. PubMed ID: 38426305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield and variant reassessment in the genes encoding Nav1.5 channel in Russian patients with Brugada syndrome.
    Zaklyazminskaya E; Shestak A; Podolyak D; Komoliatova V; Makarov L; Novitskaya A; Revishvili A
    Front Pharmacol; 2022; 13():984299. PubMed ID: 36091819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A calibrated functional patch-clamp assay to enhance clinical variant interpretation in KCNH2-related long QT syndrome.
    Jiang C; Richardson E; Farr J; Hill AP; Ullah R; Kroncke BM; Harrison SM; Thomson KL; Ingles J; Vandenberg JI; Ng CA
    Am J Hum Genet; 2022 Jul; 109(7):1199-1207. PubMed ID: 35688147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Ishikawa T; Kimoto H; Mishima H; Yamagata K; Ogata S; Aizawa Y; Hayashi K; Morita H; Nakajima T; Nakano Y; Nagase S; Murakoshi N; Kowase S; Ohkubo K; Aiba T; Morimoto S; Ohno S; Kamakura S; Nogami A; Takagi M; Karakachoff M; Dina C; Schott JJ; Yoshiura KI; Horie M; Shimizu W; Nishimura K; Kusano K; Makita N
    Eur Heart J; 2021 Jul; 42(29):2854-2863. PubMed ID: 34219138
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kroncke BM; Glazer AM; Smith DK; Blume JD; Roden DM
    Circ Genom Precis Med; 2018 May; 11(5):e002095. PubMed ID: 29728395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Assays Reclassify Suspected Splice-Altering Variants of Uncertain Significance in Mendelian Channelopathies.
    O'Neill MJ; Wada Y; Hall LD; Mitchell DW; Glazer AM; Roden DM
    Circ Genom Precis Med; 2022 Dec; 15(6):e003782. PubMed ID: 36197721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical interpretation of KCNH2 variants using a robust PS3/BS3 functional patch-clamp assay.
    Thomson KL; Jiang C; Richardson E; Westphal DS; Burkard T; Wolf CM; Vatta M; Harrison SM; Ingles J; Bezzina CR; Kroncke BM; Vandenberg JI; Ng CA
    HGG Adv; 2024 Apr; 5(2):100270. PubMed ID: 38219013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in the SCN5A Promoter Associated With Various Arrhythmia Phenotypes.
    Yagihara N; Watanabe H; Barnett P; Duboscq-Bidot L; Thomas AC; Yang P; Ohno S; Hasegawa K; Kuwano R; Chatel S; Redon R; Schott JJ; Probst V; Koopmann TT; Bezzina CR; Wilde AA; Nakano Y; Aiba T; Miyamoto Y; Kamakura S; Darbar D; Donahue BS; Shigemizu D; Tanaka T; Tsunoda T; Suda M; Sato A; Minamino T; Endo N; Shimizu W; Horie M; Roden DM; Makita N
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
    J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records.
    Van Driest SL; Wells QS; Stallings S; Bush WS; Gordon A; Nickerson DA; Kim JH; Crosslin DR; Jarvik GP; Carrell DS; Ralston JD; Larson EB; Bielinski SJ; Olson JE; Ye Z; Kullo IJ; Abul-Husn NS; Scott SA; Bottinger E; Almoguera B; Connolly J; Chiavacci R; Hakonarson H; Rasmussen-Torvik LJ; Pan V; Persell SD; Smith M; Chisholm RL; Kitchner TE; He MM; Brilliant MH; Wallace JR; Doheny KF; Shoemaker MB; Li R; Manolio TA; Callis TE; Macaya D; Williams MS; Carey D; Kapplinger JD; Ackerman MJ; Ritchie MD; Denny JC; Roden DM
    JAMA; 2016 Jan; 315(1):47-57. PubMed ID: 26746457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.
    Kapplinger JD; Giudicessi JR; Ye D; Tester DJ; Callis TE; Valdivia CR; Makielski JC; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2015 Aug; 8(4):582-95. PubMed ID: 25904541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCN5A-C683R exhibits combined gain-of-function and loss-of-function properties related to adrenaline-triggered ventricular arrhythmia.
    Steinberg C; Pilote S; Philippon F; Laksman ZW; Champagne J; Simard C; Krahn AD; Drolet B
    Exp Physiol; 2021 Mar; 106(3):683-699. PubMed ID: 33480457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant frequencies of KCNQ1, KCNH2, and SCN5A in a Chinese inherited arrhythmia cohort and other disease cohorts undergoing genetic testing.
    Li X; Liu N; Bai R
    Ann Hum Genet; 2020 Mar; 84(2):161-168. PubMed ID: 31696929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between sodium channel function and clinical phenotype in SCN5A variants associated with Brugada syndrome.
    Pearman CM; Denham NC; Mills RW; Ding WY; Modi SS; Hall MCS; Todd DM; Mahida S
    Hum Mutat; 2020 Dec; 41(12):2195-2204. PubMed ID: 33131149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of automated patch clamp assays to overcome the burden of variants of uncertain significance in inheritable arrhythmia syndromes.
    Ma JG; Vandenberg JI; Ng CA
    Front Physiol; 2023; 14():1294741. PubMed ID: 38089476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.